Alzex Neuropharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	2006
Period Ending	Feb '26 Feb 5, 2026	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	2006
Market Capitalization	0	0	1	0	6	-	Upgrade
Market Cap Growth	-99.94%	-63.78%	174.42%	-91.75%	-	-	Upgrade
Enterprise Value	-	1	2	2	7	-	Upgrade
Last Close Price	0.00	240.00	900.01	1500.02	18000.18	-	Upgrade
PE Ratio	0.01	14.51	16.10	-	25.46	-	Upgrade
PS Ratio	0.00	0.10	0.34	0.05	0.38	-	Upgrade
PB Ratio	0.00	0.45	1.07	0.75	17.18	-	Upgrade
P/FCF Ratio	-	1.62	17.85	-	16.53	-	Upgrade
P/OCF Ratio	0.00	1.62	17.85	-	15.87	-	Upgrade
EV/Sales Ratio	-	0.23	0.63	0.20	0.49	-	Upgrade
EV/EBITDA Ratio	-	118.32	13.13	-	-	-	Upgrade
EV/EBIT Ratio	-	-	21.37	-	-	-	Upgrade
EV/FCF Ratio	-	3.81	33.47	-	21.29	-	Upgrade
Debt / Equity Ratio	0.60	0.60	0.70	2.13	4.21	-39.98	Upgrade
Debt / EBITDA Ratio	67.41	67.41	4.56	-	-	-	Upgrade
Debt / FCF Ratio	2.17	2.17	11.64	-	4.05	1.45	Upgrade
Net Debt / Equity Ratio	0.49	0.49	0.65	2.13	4.07	-37.87	Upgrade
Net Debt / EBITDA Ratio	55.19	55.19	4.27	-5.01	-7.31	-5.53	Upgrade
Net Debt / FCF Ratio	1.78	1.78	10.88	-5.54	3.92	1.37	Upgrade
Asset Turnover	2.25	2.25	1.70	4.13	6.96	6.99	Upgrade
Quick Ratio	1.40	1.40	1.82	2.70	1.47	2.16	Upgrade
Current Ratio	1.43	1.43	1.91	2.72	1.53	2.28	Upgrade
Return on Equity (ROE)	2.85%	2.85%	8.75%	-69.49%	157.92%	-206.92%	Upgrade
Return on Assets (ROA)	-1.64%	-1.64%	3.14%	-7.95%	-6.10%	-9.76%	Upgrade
Return on Capital Employed (ROCE)	-3.30%	-3.30%	5.40%	-13.30%	-12.20%	-18.00%	Upgrade
Earnings Yield	7091.37%	6.89%	6.21%	-70.64%	3.93%	-	Upgrade
FCF Yield	-	61.58%	5.60%	-50.93%	6.05%	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.